Pharmaceutical

UK MHRA approves Advanz Pharma antibiotic for complex infections

The UK MHRA has approved Advanz Pharma’s combined antibiotic, cefepime/enmetazobactam, to treat complicated infections.

Apr 7, 2024 - 00:00
UK MHRA approves Advanz Pharma antibiotic for complex infections
The UK MHRA has approved Advanz Pharma’s combined antibiotic, cefepime/enmetazobactam, to treat complicated infections.
Read the original article

Tags:

Previous Article

Caris and Merck KGaA link to develop ADCs for cancer treatment

Next Article

Q&A: BARDA wants to back tech that can combat multiple infections, says director

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: In surprise move, FDA calls for advisory committee on Lilly’s Alzheimer’s drug

STAT+: In surprise move, FDA calls for advisory committ...

Mar 8, 2024

Rystiggo receives FDA approval, strengthening UCB’s myasthenia gravis portfolio

Rystiggo receives FDA approval, strengthening UCB’s mya...

Jun 27, 2023

Biotech execs vie for a share of obesity drug boom: ‘It’s the early innings’

Biotech execs vie for a share of obesity drug boom: ‘It...

Sep 8, 2023